相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification
Jamal S. Rana et al.
AMERICAN JOURNAL OF MEDICINE (2022)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome
Bradley Sarak et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)
Provisional Mortality Data - United States, 2020
Farida B. Ahmad et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US
Christopher P. Cannon et al.
JAMA CARDIOLOGY (2021)
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System)
Xiaoming Jia et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?
Ann Marie Navar et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016
Robert J. Romanelli et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
Xiaoxi Yao et al.
JAMA NETWORK OPEN (2020)
Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
Gloria Lena Vega et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries
Vera Bittner et al.
JAMA CARDIOLOGY (2019)
Therapeutic Inertia in Cardiovascular Disease Prevention Time to Move the Bar
Dave L. Dixon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Ischemic Event Rates in Very-High-Risk Adults
Lisandro D. Colantonio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers
Jalpa A. Doshi et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers
Jalpa A. Doshi et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol
Teresa N. Harrison et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial
Ezra Fishman et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013 Insights From the Medical Expenditure Panel Survey
Joseph A. Salami et al.
JAMA CARDIOLOGY (2017)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System
Thomas R. Radomski et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2016)
Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction
Kamil F. Faridi et al.
JAMA CARDIOLOGY (2016)
Optimal Use of Available Claims to Identify a Medicare Population Free of Coronary Heart Disease
Shia T. Kent et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Validation Study of Medicare Claims to Identify Older US Adults With CKD Using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Paul Muntner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims
Hiraku Kumamaru et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
S. Matthijs Boekholdt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review
Natalie McCormick et al.
PLOS ONE (2014)
Association of early follow-up after acute myocardial infarction with higher rates of medication use
Stacie L. Daugherty et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
National health care costs of peripheral arterial disease in the Medicare population
Alan T. Hirsch et al.
VASCULAR MEDICINE (2008)
A modified Poisson regression approach to prospective studies with binary data
GY Zou
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
分享论文
